For example, Novo Nordisk's oral formulation of semaglutide for diabetes Rybelsus needs to be dosed in the fasting state, with patients not eating or drinking for at least 30 minutes afterwards
At the currently approved maximum dose of 14mg, the PIONEER clinical trials showed weight loss of approximately 4-5kg (about 4-5% of body weight) over 26 weeks in patients with type 2 diabetes
Vomiting: Less frequent than nausea but still notable, especially at higher doses
This helps explain how semaglutide may be linked to orthostatic hypotension
As with all subcutaneous injectable medications, retatrutide may cause localised reactions at the injection site
The Phase 2 clinical trial showed roughly 2-3 kg more fat loss than placebo over 12 weeks, with no impact on blood sugar, insulin, IGF-1, or any hormonal marker